A new 30,000-square foot space is dedicated to “early stage” companies specializing in the biotech, pharmaceutical, medical device and health tech industries.
In the span of one month, L'Oréal has expanded its portfolio three times through a licensing agreement with Valentino and the acquisition of two companies.